These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 9284981)

  • 1. Exposure chamber for allergen challenge. A placebo-controlled, double-blind trial in house-dust-mite asthma.
    Rønborg SM; Mosbech H; Poulsen LK
    Allergy; 1997 Aug; 52(8):821-8. PubMed ID: 9284981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Der p 1 and Der p 2 induce less severe late asthmatic responses than native Dermatophagoides pteronyssinus extract after a similar early asthmatic response.
    Van Der Veen MJ; Jansen HM; Aalberse RC; van der Zee JS
    Clin Exp Allergy; 2001 May; 31(5):705-14. PubMed ID: 11422129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allergen-induced bronchial inflammation in house dust mite-allergic patients with or without asthma.
    Lopuhaä CE; Out TA; Jansen HM; Aalberse RC; van der Zee JS
    Clin Exp Allergy; 2002 Dec; 32(12):1720-7. PubMed ID: 12653162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of house dust mite avoidance measures on Der p 1 concentrations and clinical condition of mild adult house dust mite-allergic asthmatic patients, using no inhaled steroids.
    Cloosterman SG; Schermer TR; Bijl-Hofland ID; Van Der Heide S; Brunekreef B; Van Den Elshout FJ; Van Herwaarden CL; Van Schayck CP
    Clin Exp Allergy; 1999 Oct; 29(10):1336-46. PubMed ID: 10520054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of anti-allergic mattress encasings on house dust mite-induced early- and late-airway reactions in asthmatic patients. A double-blind, placebo-controlled study.
    Rijssenbeek-Nouwens LH; Oosting AJ; De Monchy JG; Bregman I; Postma DS; De Bruin-Weller MS
    Clin Exp Allergy; 2002 Jan; 32(1):117-25. PubMed ID: 12002728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of atopic dermatitis by inhalation of house dust mite.
    Tupker RA; De Monchy JG; Coenraads PJ; Homan A; van der Meer JB
    J Allergy Clin Immunol; 1996 May; 97(5):1064-70. PubMed ID: 8626983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seasonal variation of skin reactivity and specific IgE antibody to house dust mite.
    Nahm DH; Park HS; Kang SS; Hong CS
    Ann Allergy Asthma Immunol; 1997 Jun; 78(6):589-93. PubMed ID: 9207724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of sublingual immunotherapy in children with asthma and rhinitis: a double-blind, placebo-controlled study.
    Bahçeciler NN; Işik U; Barlan IB; Başaran MM
    Pediatr Pulmonol; 2001 Jul; 32(1):49-55. PubMed ID: 11416876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. House dust mite and cockroach exposure are strong risk factors for positive allergy skin test responses in the Childhood Asthma Management Program.
    Huss K; Adkinson NF; Eggleston PA; Dawson C; Van Natta ML; Hamilton RG
    J Allergy Clin Immunol; 2001 Jan; 107(1):48-54. PubMed ID: 11149990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 1-year, placebo-controlled, double-blind house-dust-mite immunotherapy study in asthmatic adults.
    Olsen OT; Larsen KR; Jacobsan L; Svendsen UG
    Allergy; 1997 Aug; 52(8):853-9. PubMed ID: 9284985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of household dust mite exposure and levels of specific IgE and IgG antibodies in asthmatic patients enrolled in a trial of immunotherapy.
    Rose G; Arlian L; Bernstein D; Grant A; Lopez M; Metzger J; Wasserman S; Platts-Mills TA
    J Allergy Clin Immunol; 1996 May; 97(5):1071-8. PubMed ID: 8626984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discrepancies between in vitro and in vivo tests for house dust mite allergy: in domestic exposure a better predictor than sensitization?
    Niggemann B; Kleinau I; Schou C; Hansen GN; Wahn U
    Clin Exp Allergy; 1994 Oct; 24(10):946-8. PubMed ID: 7531110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase in allergen-specific IgE and ex vivo Th2 responses after a single bronchial challenge with house dust mite in allergic asthmatics.
    van de Pol MA; Lutter R; van Ree R; van der Zee JS
    Allergy; 2012 Jan; 67(1):67-73. PubMed ID: 21958117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exposure to house dust mite allergens and the clinical activity of asthma.
    Custovic A; Taggart SC; Francis HC; Chapman MD; Woodcock A
    J Allergy Clin Immunol; 1996 Jul; 98(1):64-72. PubMed ID: 8765819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of allergen-induced late inflammatory reactions in the nose and in the skin in house dust mite-allergic patients with or without asthma.
    Lopuhaä CE; de Riemer MJ; Out TA; Sjamsoedin DH; Aalberse RC; Jansen HM; van der Zee JS
    Int Arch Allergy Immunol; 2003 Apr; 130(4):266-74. PubMed ID: 12740527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. False-positive skin prick test responses to commercially available dog dander extracts caused by contamination with house dust mite (Dermatophagoides pteronyssinus) allergens.
    van der Veen MJ; Mulder M; Witteman AM; van Ree R; Aalberse RC; Jansen HM; van der Zee JS
    J Allergy Clin Immunol; 1996 Dec; 98(6 Pt 1):1028-34. PubMed ID: 8977501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of current exposure to Der p 1 on asthma symptoms, airway inflammation, and bronchial hyperresponsiveness in mite-allergic asthmatics.
    Alvarez MJ; Olaguibel JM; Acero S; García BE; Tabar AI; Urbiola E
    Allergy; 2000 Feb; 55(2):185-90. PubMed ID: 10726735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo biological activity of recombinant Der p II allergen of house-dust mite.
    Lynch NR; Thomas WR; Chua Y; García N; Di Prisco MC; López R
    Int Arch Allergy Immunol; 1994 Sep; 105(1):70-4. PubMed ID: 7522071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bronchial allergen challenge with isolated major allergens of Dermatophagoides pteronyssinus: the role of patient characteristics in the early asthmatic response.
    van der Veen MJ; Lopuhaä CE; Aalberse RC; Jansen HM; van der Zee JS
    J Allergy Clin Immunol; 1998 Jul; 102(1):24-31. PubMed ID: 9679844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of continuous allergen challenge on clinical symptoms and mediator release in dust-mite-allergic patients.
    Horak F; Toth J; Hirschwehr R; Marks B; Stübner UP; Jäger S; Berger U; Schleinzer K; Günczler P
    Allergy; 1998 Jan; 53(1):68-72. PubMed ID: 9491231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.